New lead at French biotech company
French biotech company, Deinove, which uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for animal nutrition and cosmetics, has appointed Alexis Rideau as its new CEO.
Prior to joining Deinove, Rideau was in charge of developing industrial relations and coordinating the strategic partnership team at Bioaster (Lyon/Paris), a technology research institute in applied microbiology solutions for animal and human health.
He holds a PhD in Molecular and Cellular Biology from the University of Cambridge in the UK and a European Magistère in Genetics and an MSc in Cellular and Molecular Genetics from the Diderot University and Sorbonne University in Paris, as well as an MBA in International Management from ESCP Europe.
